SOURCE: Industrial Info Resources

Industrial Info Resources

December 20, 2010 05:20 ET

From Cannabis to Catheters, Pharma-Biotech Industry Closes Out 2010 With 85 New Facilities and $7.1 Billion Potential Investment, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - December 20, 2010) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As 2010 draws to a close, the Pharmaceutical-Biotech Industry will have completed construction on a total of 85 new plants and research centers across North America. Each as diverse as the industry itself, a recent survey of reported projects in Industrial Info's Pharmaceutical Tracker -- Online Database reveals that cumulatively, the projects represent a potential total investment value (TIV) of $7.1 billion, which includes both original construction costs and possible future phases that are already planned or under consideration.

The industry's crown jewel for the year is the $1 billion Novartis AG (NYSE:NVS) (Basel, Switzerland) vaccine-manufacturing campus in Holly Springs, North Carolina. BE&K Building Group and Jacobs Engineering Group Incorporated (NYSE:JEC) worked together to build the more than 430,000-square-foot facility.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=170874, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Follow us on: Facebook - Twitter - LinkedIn - Vimeo